Who is at risk after risk reduction?

Publisher: John Wiley & Sons Inc

E-ISSN: 1097-0142|124|5|884-887

ISSN: 0008-543x

Source: CANCER, Vol.124, Iss.5, 2018-03, pp. : 884-887

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

After gynecologic risk‐reducing surgery, BRCA1/2 mutation carriers remain at risk of developing primary peritoneal cancer. The study by Harmsen et al in this issue of Cancer provides information regarding who might be at greater risk after risk‐reduction surgery.See also pages 952‐9.